Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
oleh: M Klingebiel, C Arsov, T Ullrich, M Quentin, R Al-Monajjed, D Mally, LM Sawicki, A Hiester, I Esposito, P Albers, G Antoch, L Schimmöller
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2022-12-01 |
Deskripsi
This is a data article from the original publication “Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy” [1]. From January 2014 to April 2019 a sample collective of 785 patients with 3T multiparametric magnetic resonance imaging (mp-MRI) of the prostate and subsequent combined systematic biopsy (SB) and magnetic resonance imaging/ultrasound (US) fusion-guided biopsy (TB) was retrospectively analyzed. Prostate cancer (PCa) detection by TB and/or additional SB was analyzed.